What is a Spectranetics laser?
In peripheral vascular intervention, Spectranetics’ excimer laser system uses ultraviolet light to ablate blockages associated with peripheral arterial disease above and below-the-knee and to treat multiple morphology lesions comprising atheroma, fibrosis, calcium, and thrombus.
What are excimer lasers used for?
They are most commonly used to correct myopia (nearsightedness) but can also be used to correct hyperopia (farsightedness) and astigmatism. The excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea through a process known as photoablative decomposition.
Is spectranetics a part of Philips?
Spectranetics’ financial results will be consolidated as part of Philips’ Image-Guided Therapy business group as of August 9, 2017. Spectranetics is currently growing double-digits and projects 2017 sales to be approximately USD 300 million. The company employs over 900 employees.
What is a laser atherectomy catheter?
Laser atherectomy is an FDA-approved, minimally invasive endovascular technique for removing plaque from blood vessels within the body. The procedure uses a catheter that emits high-energy ultraviolet light to unblock the artery. Dr. Lam maneuvers the catheter through the vessel until it reaches the blockage.
How do excimer lasers work?
How do excimer lasers work? The excimer laser emits a cool beam of ultraviolet light of a specific wavelength (typically 193 nanometers) to precisely remove corneal tissue. When the surface of the cornea is reshaped in the right way, it allows light rays to focus properly onto the retina for clear vision.
What is meant by excimer laser?
Excimer lasers are light pulse-emitting gas lasers, forming an excited dimer by an electric discharge of a gas mixture containing an inert gas and a halogen gas that produces a molecule ArF⁎ that exists only in the excited state (⁎) with life times of the order of 20ns.
Who bought Spectranetics?
Royal Philips
Healthcare technology Dutch giant Royal Philips will purchase Spectranetics, a Colorado-based company that employs vascular intervention to treat coronary and peripheral artery disease. Philips announced it would pay $2.2 billion for the acquisition. The board of directors of Spectranetics approved the transaction.
Is atherectomy better than angioplasty?
The authors conclude that directional coronary atherectomy provides better clinical and angiographic outcomes in patients with coronary artery disease than primary stenting during angioplasty. They also emphasize that relatively large vessels are most suitable for directional coronary atherectomy.
What does excimer laser mean?
Excimer is a term used today to describe a family of lasers with similar output characteristics, in that they all emit powerful pulses lasting nanoseconds or tens of nanoseconds, at wavelengths in or near the ultraviolet, and the lasing medium is a diatomic molecule, or dimer, in which the component atoms are bound in …
What is the basic principle of excimer laser?
In an excimer laser, a pulsed gas discharge produces excited molecules with a nonbinding electronic ground state. This means that these molecules disassociate after spontaneous or stimulated emission, so that reabsorption of the radiation is not possible.
Why choose Spectranetics?
At Spectranetics, we are focusing on proven algorithms of treatment for the most complex and challenging cardiovascular cases. Learn more > Coronary Intervention Coronary Artery Disease is the leading cause of death among men and women.
What is the Spectranetics cvx-300 excimer laser system?
What Is the Spectranetics CVX-300 Excimer Laser System? The CVX-300 is a laser system that emits ultraviolet light to break up hardened plaque from artery walls. The technology is designed to minimize damage to surrounding soft tissue and reduce complications during use.
What is life lived fully Spectranetics?
Spectranetics is now part of Philips VIEW THE PRESS RELEASE Life Lived Fully Spectranetics is helping patients return to the activities they love. HEAR THE STORY